Industry Veteran Joins Intranasal Therapeutics

BioPharm International Editors

Intranasal Therapeutics, Inc. (ITI, Montvale, NJ, www.intranasal.com), has appointed Peter F. Young as president and chief executive officer.

Intranasal Therapeutics, Inc. (ITI, Montvale, NJ, www.intranasal.com), has appointed Peter F. Young as president and chief executive officer. Young was most recently the president and CEO of AlphaVax, a North Carolina-based biotechnology company. While at AlphaVax, Young grew that company from six to 75 employees and advanced its technology from the academic bench to human clinical trials.